medigraphic.com
ISSN 0016-3813 (Print)

2016, Number S2

<< Back Next >>

Gac Med Mex 2016; 152 (S2)

Assessment and Intervention Thresholds to Detect Cases at Risk of Osteoporosis and Fragility Fractures with FRAX® in a Mexican Population for the First Level of Healthcare

Clark P, Ramírez-Pérez E, Reyes-López A

Language: Spanish
References: 20
Page: 22-31
PDF size: 125.09 Kb.


ABSTRACT

Objective: To estimate the evaluation and intervention thresholds using FRAX® in Mexican population. Methods: Probabilities for a mayor fracture using the Mexican FRAX® version to estimate the evaluation and intervention thresholds using clinical scenarios were obtained in both sexes 40 years and over. Projections for 2020 were done to estimate the number of patients at the intervention level taking the osteoporosis prevalence in Mexicans aged 50 years and over. Results: The cutoffs for the intervention thresholds were 2.6%-20.0%. Individuals with thresholds above these probabilities are amenable for intervention. The assessment thresholds range from 1.2-3.2% to 12.5-24.4% for 40 to 90 years. According to projections of our population approximately three million people are susceptible to intervention by 2020. Conclusion: The use of FRAX® thresholds of intervention and evaluation developed in this study will be useful in the primary care level for case detection at high risk of fragility fracture.


REFERENCES

  1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465-75.

  2. Clark P, Cons-Molina F, Deleze M, Talavera JO, Palermo L, Cummings SO. The prevalence of radiographic vertebral fractures in Mexican men. Osteoporos Int. 2010;21:1523-8.

  3. Clark P, Cons-Molina F, Deleze M, et al. The prevalence of radiographic vertebral fractures in Latin American countries: the Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int. 2009;20:275-82.

  4. Clark P, Lavielle P, Franco-Marina F, et al. Incidence rates and life-time risk of hip fractures in Mexicans over 50 years of age: a population- based study. Osteoporos Int. 2005;16:2025-30.

  5. Johansson H, Clark P, Carlos F, Oden A, McCloskey EV, Kanis JA. Increasing age- and sex-specific rates of hip fracture in Mexico: a survey of the Mexican Institute of Social Security. Osteoporos Int. 2011;22:2359-64.

  6. Carlos F, Clark P, Galindo-Suarez RM, Chico-Barba LG. Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico. Arch Osteoporos. 2013;8:125.

  7. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368-81.

  8. Melton LJ, 3rd, Atkinson EJ, O’Fallon WM, Wahner HW, Riggs BL. Longterm fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res. 1993;8:1227-33.

  9. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286:2815-22.

  10. WHO Scientific Group on the assessment of osteoporosis at primary health care level. Geneva, Switzerland: World Heath Organization; 2007.

  11. Johnell O, Kanis JA. An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int. 2004;15:897-902.

  12. FRAX®. Herramienta de evaluación de riesgo de fractura desarrollada por la Organización Mundial de la Salud (OMS). 2016. (Consultado el 8/8/16.) Disponible en: https://www.shef.ac.uk/FRAX/tool.jsp?lang=sp

  13. Kanis JA, McCloskey EV, Johansson H, et al. Case finding for the management of osteoporosis with FRAX − assessment and intervention thresholds for the UK. Osteoporos Int. 2008;19:1395-408.

  14. Royal Collegue of Physicians L. Osteoporosis: clinical guidelines for the prevention and treatment of osteoporosis. 1999.

  15. Diagnóstico y tratamiento de osteoporosis en mujeres posmenopáusicas. 2013. Secretaría de Salud. (Consultado en 2016.) Disponible en: http://www.cenetec.salud.gob.mx/descargas/gpc/CatalogoMaestro/ IMSS_673_13_Osteoporosisenpostmenopausia/673GER.pdf

  16. Kanis JA, Oden A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012;23:2239-56.

  17. Clark P, Tamayo JA, Cisneros F, Rivera FC, Valdes M. Epidemiology of osteoporosis in Mexico. Present and future directions. Rev Invest Clin. 2013;65:183-91.

  18. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1-129.

  19. Rubin KH, Friis-Holmberg T, Hermann AP, Abrahamsen B, Brixen K. Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res. 2013;28:1701-17.

  20. Tosteson AN, Melton LJ, 3rd, Dawson-Hughes B, et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int. 2008;19:437-47.




2020     |     www.medigraphic.com